Drug intelligence / Profile preview

compound ossotide for injection

Development stage
Unknown
Lead developer
Heilongjiang Jiangshi Pharmaceutical
Modality
Peptides
Administration
Intramuscular, Intravenous
01

Overview

**Gujie** is a Chinese prescription injectable product containing compound ossotide, an animal-derived peptide preparation made from extracts of healthy pig limb bones and whole scorpion. It is supplied as a sterile lyophilized preparation for injection and is manufactured by Heilongjiang Jiangshi Pharmaceutical. The product is indicated in China for symptomatic improvement in rheumatism, rheumatoid arthritis, osteoporosis, and cervical spondylosis, and to support bone healing after fractures and orthopedic surgery. Its pharmacology is not defined by a single molecular target; product information describes anti-inflammatory and analgesic activity and attributes bone-healing effects to a mixture of bone growth factors and peptides that may modulate bone metabolism, bone calcium handling, callus formation, and neovascularization. ([ypk.39.net](https://ypk.39.net/728511/manual/))

Brand names
Gujie古杰
Other names
Compound Bone Peptide for InjectionCompound Ossotide for InjectionZhusheyong Fufang Gutai注射用复方骨肽
02

Targets

TGFBR (TGF-beta receptor)Neuraminidase

Beyond the preview

Go deeper on compound ossotide for injection.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on compound ossotide for injection.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call